Trisomy 8 Involved in Myelodysplastic Syndromes as a Risk Factor for Intestinal Ulcers and Thrombosis — Behçet's Syndrome

Leukemia and Lymphoma

Volumn 42, Issue 42006, 2001, Pages 115-121

  Kimura, Shinya ^a,b   Kuroda, Junya ^a,b   Akaogi, Teruaki ^a   Hayashi, Hideo ^a   Kobayashi, Yutaka ^b   Kondo, Motoharu ^a  

^a KYOTO SECOND RED CROSS HOSPITAL   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Beh et's syndrome; intestinal ulcer; myelodysplastic syndrome; thrombosis; trisomy 8

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; MYC PROTEIN; PREDNISOLONE; REACTIVE OXYGEN METABOLITE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BEHCET DISEASE; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL OBSERVATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG SAFETY; FEMALE; FEVER; HOSPITAL CARE; HUMAN; INTESTINE ULCER; MALE; MOUTH ULCER; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SYMPTOMATOLOGY; THROMBOSIS; TRISOMY 8;

ADULT; AGED; AGED, 80 AND OVER; BEHCET SYNDROME; CHROMOSOMES, HUMAN, PAIR 8; CYTOGENETIC ANALYSIS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PEPTIC ULCER; RISK FACTORS; THROMBOSIS; TRISOMY;

EID: 0034928263     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428190109097683     Document Type: Article

References (29)

1. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A.G., Gralnick H. R., Sultan C. Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology 1982; 51: 189 – 199
2. Boogaerts M. A., Nelissen V., Roelant C., Goossens W. Blood neutrophil function in primary myelodysplastic syndromes. British Journal of Haematology 1983; 55: 217 – 227
3. Tsurumi H., Shimazaki M., Takahashi T., Moriwaki H., Muto Y. How cytometric determination of active oxygen (hydroperoxide) produced by peripheral blood neutrophils in patients with hematological disorders. International Journal of Hematology 1993; 57: 213 – 219
4. Yuo A., Kitagawa S., Okabe T., Urabe A., Komatsu Y., Itoh S., Takaku F. Recombinant human granulocyte colony-stimulating factor repairs the abnormalities of neutrophils in patients with myelodysplastic syndromes and chronic myelogenous leukemia. Blood 1987; 70: 404 – 411
5. Niwa Y., Miyake S., Sakane T., Shingu M., Yokoyama M. Auto-oxidative damage in Behcet's disease-endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clinical Experimental Immunology 1982; 49: 247 – 255
6. Nehashi Y., Torii Y., Yaguchi M., Itoh Y., Ohyashiki K., Toyama K. Incomplete-form of Behçet disease in a case of monopathic myelodysplastic syndrome presenting as a thrombocytopenia. Japanese Journal of Clinical Hematology 1988; 29: 1097 – 1102
7. Nakayama S., Ishikawa T., Yabe H., Nagai K. Refractory anemia complicated by Behçet's disease. Japanese Journal of Clinical Hematology 1989; 30: 530 – 534
8. Chyuma Y., Utsunomiya A., Saito T., Hanada S., Nishimata H., Arima T. Hemolytic anemia complicated with Behçet's disease and myelodysplastic syndrome. Japanese Journal of Clinical Hematology 1992; 33: 333 – 337
9. Takishita N., Horiuchi T., Hato T., Fujita S., Kobayashi Y. Myelodysplastic syndrome complicated with Behçet's disease. Ehime Igaku 1991; 11: 39 – 43
10. Molina M., Aguayo J. L., Ortega G., de Paco M., Cuesta F., Agudo M. D. Non-specific digestive ulcers and Behçet's disease. Anates de Medicina Interna 1992; 9: 237 – 238
11. Yoshizawa Y., Hirai A., Izaki S., Kitamura K. Behçet's disease associated with myelodysplastic disorder. Hifu Rinsyo 1992; 34: 1585 – 1589
12. Kageyama H., Hidaka T., Kondo S., Tamaru K. Intestinal Behçet's disease associated with myelodysplastic syndrome. Japanese Journal of Clinical Hematology 1993; 34: 1288
13. Yano K., Eguchi K., Migita K., Takashima H., Tamura M., Izumino K., Sasagawa I., Sadamori N., Nagataki S. Behçet's disease complicated with myelodysplastic syndrome. A report of two cases and review of the literature. Clinical Rheumatology 1996; 15: 91 – 93
14. Ohno E., Ohtsuka E., Watanabe K., Kohno T., Takeoka K., Saburi Y., Kikuchi H., Nasu M. Behçet's disease associated with myelodysplastic syndromes. Cancer 1997; 79: 262 – 268
15. Mitelman F. ISCN Guidelines for Cancer Cytogenetics. Supplement to an International System for Human Cytogenetic Nomenclature. Karger, Basel Switzerland 1995
16. Kuroda J., Kimura S., Akaogi T., Hayashi H., Nishida K., Taniwaki M., Kashima K., Abe T., Kobayashi Y, Kondo M. c-myc overexpression is not mandatory in aggressive phase multiple myeloma with Burkitt's type translocation. Annals of Hematology, in press
17. Takada Y., Fujita Y., Igarashi M., Katsumata T., Okabe H., Saigenji K., Takahashi T., Atari E. Intestinal Behçet's disease-pathognomonic changes in intramucosal lymphoid tissues and effect of a “rest cure” on intestinal leisions. Journal of Gastroenterology 1997; 32: 598 – 604
18. Ohno S. Behçet's disease in the world. Recent advances in Behçet's disease, T. Lehner, C. G. Barnes. Royal Society of Medicine Service, New York 1986; 181–186
19. Sole F., Prieto F., Badia L., Woessner S., Florensa L., Caballin M. R., Coll M. D., Besses C., Sans-Sabrafen J. Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes. Cancer Genetics and Cytogenetics 1992; 64: 12 – 20
20. Ohno S., Matsuda H. Studies of HLA antigens in Behçet's disease in Japan. Recent advances in Behçet's disease, T. Lehner, C. G. Barnes. Royal Society of Medicine Service, New York 1986; 11–15
21. Negrin R. S., Haeuber D. H., Nagler A., Kobayashi Y., Sklar J., Donlon T., Vincent M., Greenberg P. L. Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor. Blood 1990; 76: 36 – 43
22. Saitoh K., Miura I., Takahashi N., Miura A. B. Fluorescence in situ hybridization of progenitor cells obtained by fluorescence-activated cell sorting for the detection of cells affected by chromosome abnormality trisomy 8 in patients with myelodysplastic syndromes. Blood 1998; 92: 2886 – 2892
23. Okamoto T., Okada M., Itoh T., Mori A., Saheki K., Takatsuka H., Wada H., Tamura A., Fujimori Y., Takemoto Y., Kanamaru A., Kakishita E. Myelodysplastic syndrome with B cell clonality in a patient five years after renal transplantation. International Journal of Hematology 1998; 68: 61 – 65
24. Billstrom R., Johansson B., Strombeck B., El-Rifai W., Larramendy M., Olofsson T., Mitelman F., Knuutila S. Clonal CD5-positive B lymphocytes in myelodysplastic syndrome with systemic vasculitis and trisomy 8. Annals of Hematology 1997; 74: 37 – 40
25. Kimura S., Maekawa T., Hirakawa K., Murakami A., Abe T. Alterations of c-myc expression by antisense oligodeoxynucleotides enhance the induction of apoptosis in HL-60 cells. Cancer Research 1995; 55: 1379 – 1384
26. Dalla-Favera R., Bregni M., Erikson J., Patterson D., Gallo R. C., Croce C. M. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proceedings of the National Academy of Sciences of the United States of America 1982; 79: 7824 – 7827
27. Diaz M. O., Le Beau M. M., Harden A., Rowley J. D. Trisomy 8 in human hematologic neoplasia and the c-myc and c-mos oncogenes. Leukemia Research 1985; 9: 1437 – 1442
28. Blick M., Romero P., Talpaz M., Kurzrock R., Shtalrid M., Andersson B., Trujillo J., Beran M., Gutterman J. Molecular characteristics of chronic myelogenous leukemia in blast crisis. Cancer Genetics and Cytogenetics 1987; 27: 349 – 356
29. Jennings B. A., Mills K. I. c-myc locus amplification and the acquisition of trisomy 8 in the evolution of chronic myeloid leukaemia. Leukemia Research 1998; 22: 899 – 903